A Recombinant Probiotic, Lactobacillus casei, Expressing the Clostridium perfringens α-toxoid, as an Orally Vaccine Candidate Against Gas Gangrene and Necrotic Enteritis

Oral immunization of mice against Clostridium perfringens epsilon toxin with a Lactobacillus casei vector vaccine expressing epsilon toxoid

(2016) Mojtaba Alimolaei et al.   INFECTION GENETICS AND EVOLUTION

Genetic and antigenic typing of Clostridium perfringens isolates from ostriches

(2014) Mojtaba Alimolaei et al.   INFECTION GENETICS AND EVOLUTION

Construction of a food-grade cell surface display system for Lactobacillus casei

(2014) Jiayang Qin et al.   MICROBIOLOGICAL RESEARCH

Vaccination with recombinant Clostridium perfringens toxoids α and β promotes elevated antepartum and passive humoral immunity in swine

(2013) Felipe M. Salvarani et al.   VACCINE

Unexpected wide substrate specificity of C. perfringens α-toxin phospholipase C

(2011) Patricia Urbina et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge

(2009) M. Mohamadzadeh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Recombinant Bacillus subtilis Expressing the Clostridium perfringens Alpha Toxoid Is a Candidate Orally Delivered Vaccine against Necrotic Enteritis

(2008) T. H. Hoang et al.   INFECTION AND IMMUNITY